Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2005 Apr;76(4):534–539. doi: 10.1136/jnnp.2004.041947

Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit

M Holtkamp 1, J Othman 1, K Buchheim 1, H Meierkord 1
PMCID: PMC1739595  PMID: 15774441

Abstract

Objective: To assess risk factors and prognosis in patients with refractory status epilepticus (RSE).

Methods: We retrospectively analysed all episodes of status epilepticus (SE) treated between 1993 and 2002 on the neurological intensive care unit (NICU) of the Charité-Universitätsmedizin Berlin. The predictive and prognostic features of RSE were compared with non-RSE (NRSE). All patients with "de novo" SE were followed up to identify the possible development of post-SE symptomatic epilepsy.

Results: A total of 83 episodes fulfilled our criteria of SE. Of these 43% were refractory to first line anticonvulsants. The mean age of patients with SE was 53.3 (SD 19) years, with only two patients younger than 18 years. Encephalitis was significantly more often the primary cause in RSE (p<0.05), whereas low levels of antiepileptic drugs were significantly more often associated with NRSE (p<0.001). Hyponatraemia within the first 24 hours after onset of status activity was significantly more often associated with RSE (p<0.05). In RSE, compared with NRSE, significantly longer duration of seizure activity (p<0.001), more frequent recurrence of epileptic activity within the first 24 hours after the end of seizure activity (p<0.001), longer stay in the NICU and in hospital (p<0.001 and p<0.01, respectively), and more frequent development of symptomatic epilepsy (p<0.05) were seen.

Conclusions: SE treated in the NICU is frequently refractory to first line anticonvulsant drugs. Encephalitis is a predictor for RSE, which is associated with markedly poor outcome, in particular, the development of post-SE symptomatic epilepsy. Thus prevention of this most severe form of SE should be the primary target of treatment of SE.

Full Text

The Full Text of this article is available as a PDF (84.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aicardi J., Chevrie J. J. Convulsive status epilepticus in infants and children. A study of 239 cases. Epilepsia. 1970 Jun;11(2):187–197. doi: 10.1111/j.1528-1157.1970.tb03880.x. [DOI] [PubMed] [Google Scholar]
  2. Aminoff M. J., Simon R. P. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med. 1980 Nov;69(5):657–666. doi: 10.1016/0002-9343(80)90415-5. [DOI] [PubMed] [Google Scholar]
  3. Barolomei F., Gastaut J. L. Complex partial status epilepticus provoked by hyponatremia. Eur Neurol. 1998 Jul;40(1):53–54. [PubMed] [Google Scholar]
  4. Cascino G. D. Generalized convulsive status epilepticus. Mayo Clin Proc. 1996 Aug;71(8):787–792. doi: 10.1016/S0025-6196(11)64844-1. [DOI] [PubMed] [Google Scholar]
  5. Cascino G. D., Hesdorffer D., Logroscino G., Hauser W. A. Morbidity of nonfebrile status epilepticus in Rochester, Minnesota, 1965-1984. Epilepsia. 1998 Aug;39(8):829–832. doi: 10.1111/j.1528-1157.1998.tb01176.x. [DOI] [PubMed] [Google Scholar]
  6. Coeytaux A., Jallon P., Galobardes B., Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology. 2000 Sep 12;55(5):693–697. doi: 10.1212/wnl.55.5.693. [DOI] [PubMed] [Google Scholar]
  7. DeLorenzo R. J., Hauser W. A., Towne A. R., Boggs J. G., Pellock J. M., Penberthy L., Garnett L., Fortner C. A., Ko D. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996 Apr;46(4):1029–1035. doi: 10.1212/wnl.46.4.1029. [DOI] [PubMed] [Google Scholar]
  8. FALCONER M. A., SERAFETINIDES E. A., CORSELLIS J. A. ETIOLOGY AND PATHOGENESIS OF TEMPORAL LOBE EPILEPSY. Arch Neurol. 1964 Mar;10:233–248. doi: 10.1001/archneur.1964.00460150003001. [DOI] [PubMed] [Google Scholar]
  9. Farrar H. C., Chande V. T., Fitzpatrick D. F., Shema S. J. Hyponatremia as the cause of seizures in infants: a retrospective analysis of incidence, severity, and clinical predictors. Ann Emerg Med. 1995 Jul;26(1):42–48. doi: 10.1016/s0196-0644(95)70236-9. [DOI] [PubMed] [Google Scholar]
  10. Glaser Carol A., Gilliam Sabrina, Schnurr David, Forghani Bagher, Honarmand Somayeh, Khetsuriani Nino, Fischer Marc, Cossen Cynthia K., Anderson Larry J., California Encephalitis Project, 1998-2000 In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis. 2003 Mar 3;36(6):731–742. doi: 10.1086/367841. [DOI] [PubMed] [Google Scholar]
  11. Hauser W. A., Anderson V. E., Loewenson R. B., McRoberts S. M. Seizure recurrence after a first unprovoked seizure. N Engl J Med. 1982 Aug 26;307(9):522–528. doi: 10.1056/NEJM198208263070903. [DOI] [PubMed] [Google Scholar]
  12. Herman Susan T. Epilepsy after brain insult: targeting epileptogenesis. Neurology. 2002 Nov 12;59(9 Suppl 5):S21–S26. doi: 10.1212/wnl.59.9_suppl_5.s21. [DOI] [PubMed] [Google Scholar]
  13. Hesdorffer D. C., Logroscino G., Cascino G., Annegers J. F., Hauser W. A. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology. 1998 Mar;50(3):735–741. doi: 10.1212/wnl.50.3.735. [DOI] [PubMed] [Google Scholar]
  14. Holtkamp M., Masuhr F., Harms L., Einhäupl K. M., Meierkord H., Buchheim K. The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists. J Neurol Neurosurg Psychiatry. 2003 Aug;74(8):1095–1099. doi: 10.1136/jnnp.74.8.1095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kennedy P. G. E., Chaudhuri A. Herpes simplex encephalitis. J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):237–238. doi: 10.1136/jnnp.73.3.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Knake S., Rosenow F., Vescovi M., Oertel W. H., Mueller H. H., Wirbatz A., Katsarou N., Hamer H. M., Status Epilepticus Study Group Hessen (SESGH) Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia. 2001 Jun;42(6):714–718. doi: 10.1046/j.1528-1157.2001.01101.x. [DOI] [PubMed] [Google Scholar]
  17. Logroscino G., Hesdorffer D. C., Cascino G., Annegers J. F., Hauser W. A. Short-term mortality after a first episode of status epilepticus. Epilepsia. 1997 Dec;38(12):1344–1349. doi: 10.1111/j.1528-1157.1997.tb00073.x. [DOI] [PubMed] [Google Scholar]
  18. Lowenstein D. H., Alldredge B. K. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993 Mar;43(3 Pt 1):483–488. doi: 10.1212/wnl.43.3_part_1.483. [DOI] [PubMed] [Google Scholar]
  19. Lowenstein D. H., Alldredge B. K. Status epilepticus. N Engl J Med. 1998 Apr 2;338(14):970–976. doi: 10.1056/NEJM199804023381407. [DOI] [PubMed] [Google Scholar]
  20. Lowenstein D. H., Bleck T., Macdonald R. L. It's time to revise the definition of status epilepticus. Epilepsia. 1999 Jan;40(1):120–122. doi: 10.1111/j.1528-1157.1999.tb02000.x. [DOI] [PubMed] [Google Scholar]
  21. Lowenstein D. H. Status epilepticus: an overview of the clinical problem. Epilepsia. 1999;40 (Suppl 1):S3–S22. doi: 10.1111/j.1528-1157.1999.tb00872.x. [DOI] [PubMed] [Google Scholar]
  22. Löscher Wolfgang. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 2002 Jun;50(1-2):105–123. doi: 10.1016/s0920-1211(02)00073-6. [DOI] [PubMed] [Google Scholar]
  23. Mayer Stephan A., Claassen Jan, Lokin Johnny, Mendelsohn Felicia, Dennis Lyle J., Fitzsimmons Brian-Fred. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002 Feb;59(2):205–210. doi: 10.1001/archneur.59.2.205. [DOI] [PubMed] [Google Scholar]
  24. Meldrum B. S., Vigouroux R. A., Brierley J. B. Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol. 1973 Aug;29(2):82–87. doi: 10.1001/archneur.1973.00490260026003. [DOI] [PubMed] [Google Scholar]
  25. Parent J. M., Lowenstein D. H. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology. 1994 Oct;44(10):1837–1840. doi: 10.1212/wnl.44.10.1837. [DOI] [PubMed] [Google Scholar]
  26. Prasad A., Worrall B. B., Bertram E. H., Bleck T. P. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia. 2001 Mar;42(3):380–386. doi: 10.1046/j.1528-1157.2001.27500.x. [DOI] [PubMed] [Google Scholar]
  27. Sagduyu A., Tarlaci S., Sirin H. Generalized tonic-clonic status epilepticus: causes, treatment, complications and predictors of case fatality. J Neurol. 1998 Oct;245(10):640–646. doi: 10.1007/s004150050260. [DOI] [PubMed] [Google Scholar]
  28. Shneker Bassel F., Fountain Nathan B. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology. 2003 Oct 28;61(8):1066–1073. doi: 10.1212/01.wnl.0000082653.40257.0b. [DOI] [PubMed] [Google Scholar]
  29. Shorvon S. Tonic clonic status epilepticus. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):125–134. doi: 10.1136/jnnp.56.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Shorvon Simon. Does convulsive status epilepticus (SE) result in cerebral damage or affect the course of epilepsy--the epidemiological and clinical evidence? Prog Brain Res. 2002;135:85–93. doi: 10.1016/S0079-6123(02)35009-X. [DOI] [PubMed] [Google Scholar]
  31. Stecker M. M., Kramer T. H., Raps E. C., O'Meeghan R., Dulaney E., Skaar D. J. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia. 1998 Jan;39(1):18–26. doi: 10.1111/j.1528-1157.1998.tb01269.x. [DOI] [PubMed] [Google Scholar]
  32. Sterns R. H., Thomas D. J., Herndon R. M. Brain dehydration and neurologic deterioration after rapid correction of hyponatremia. Kidney Int. 1989 Jan;35(1):69–75. doi: 10.1038/ki.1989.9. [DOI] [PubMed] [Google Scholar]
  33. Towne A. R., Pellock J. M., Ko D., DeLorenzo R. J. Determinants of mortality in status epilepticus. Epilepsia. 1994 Jan-Feb;35(1):27–34. doi: 10.1111/j.1528-1157.1994.tb02908.x. [DOI] [PubMed] [Google Scholar]
  34. Treiman D. M., Meyers P. D., Walton N. Y., Collins J. F., Colling C., Rowan A. J., Handforth A., Faught E., Calabrese V. P., Uthman B. M. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998 Sep 17;339(12):792–798. doi: 10.1056/NEJM199809173391202. [DOI] [PubMed] [Google Scholar]
  35. Vadlamudi L., Scheffer I. E., Berkovic S. F. Genetics of temporal lobe epilepsy. J Neurol Neurosurg Psychiatry. 2003 Oct;74(10):1359–1361. doi: 10.1136/jnnp.74.10.1359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Vignatelli Luca, Tonon Caterina, D'Alessandro Roberto, Bologna Group for the Study of Status Epilepticus Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia. 2003 Jul;44(7):964–968. doi: 10.1046/j.1528-1157.2003.63702.x. [DOI] [PubMed] [Google Scholar]
  37. Yaffe K., Lowenstein D. H. Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology. 1993 May;43(5):895–900. doi: 10.1212/wnl.43.5.895. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES